The unprecedented demand placed on healthcare systems from the COVID-19 pandemic has forced a reassessment of clinical trial conduct and feasibility. Consequently, the AKTN had
Author: aktnadmin
No benefit from drug used to reduce heart disease in kidney patients
A large-scale clinical trial finds lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.The drug is routinely
BEST-Fluids study – recruitment complete
We are delighted to announce that recruitment for BEST-Fluids is now complete, with 808 participants enrolled. Congratulations to all the study teams for your hard
get involved – goal trial consumer advisory board
Let’s hear the patient voice Are you a patient or carer who would like to be involved in how clinical trials are designed? We’d love
MRFF funding success
The IMPEDE-PKD and M-FIT trials have been successful in receiving funding via the Medical Research Future Fund (MRFF) rare cancers, rare diseases and unmet needs
Kidney medication ineffective
A major clinical trial run by the AKTN finds the drug allopurinol does not prevent worsening of kidney disease. University of Queensland researchers at the